Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive

Synthesis and quality control of [11C]Deuterodeprenyl using the automated module General Electric (GE) TRACERlab® FX C Pro

Pablo Buccino, Ingrid Kreimerman, Eduardo Savio and Henry Engler
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1251;
Pablo Buccino
1Radiopharmacy R&D, Uruguayan Center of Molecular Imaging, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ingrid Kreimerman
1Radiopharmacy R&D, Uruguayan Center of Molecular Imaging, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eduardo Savio
1Radiopharmacy R&D, Uruguayan Center of Molecular Imaging, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henry Engler
1Radiopharmacy R&D, Uruguayan Center of Molecular Imaging, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1251

Objectives [11C]Deuterodeprenyl ([11C]DED) is a reference radiotracer for the quantification of the activity of MAO-B by means of PET. This radiotracer has shown to be useful in the in vivo evaluation of neurological pathologies in which an overexpression of the glial MAO-B enzyme is found: Alzheimer disease, Creutzfeldt-Jacob disease, Temporal Lobe Epilepsy, among others. The purpose of this study was the optimization of the synthesis of [11C]Deuterodeprenyl on an automated synthetic platform and its quality control.

Methods Synthetic process begins with the production of [11C]CO2 in cyclotron (GE PETtrace 16.5MeV) via the 14N(p, α)11C nuclear reaction. [11C]CO2 was delivered from the target to the module, and trapped for purification and further reduction to [11C]CH4, which suffers iodination to yield [11C]CH3I. This is later converted into [11C]CH3OTf, which reacts with N-desmethyl-(R)-α,α-dideuterodeprenyl in butanone, 1 min at 80 C. Crude product is separated using HPLC, purified through SPE and formulated in saline. Quality control (QC) tests include appearance of solution, pH, residual solvents control (GC), chemical and radiochemical purity control (HPLC), radionucleidic purity and identity, and specific activity (SA). Microbiological purity is also evaluated.

Results Full compliance with the established specifications was achieved for the produced radiotracer. EOS activity for [11C]DED ranged between 3.9 - 4.4 GBq (Radiochemical Yield from [11C]CO2: 2.1-2.4% ndc). SA is in the range 75-88 GBq/umol. Total synthesis time was 35 min (including purification and formulation) and QC analyses were carried out in 15 min. Two simultaneous PET scans could be acquired with one batch of this radiotracer.

Conclusions A methodology for the production of [11C]DED using the automated synthetic platform TRACERlab FX C Pro has been developed. This methodology enables to produce injectable [11C]DED if GMP guidelines are followed, in agreement with both USP or EP specifications, or literature data.

Research Support PEDECIBA Química

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 55, Issue supplement 1
May 2014
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Synthesis and quality control of [11C]Deuterodeprenyl using the automated module General Electric (GE) TRACERlab® FX C Pro
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Synthesis and quality control of [11C]Deuterodeprenyl using the automated module General Electric (GE) TRACERlab® FX C Pro
Pablo Buccino, Ingrid Kreimerman, Eduardo Savio, Henry Engler
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1251;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Synthesis and quality control of [11C]Deuterodeprenyl using the automated module General Electric (GE) TRACERlab® FX C Pro
Pablo Buccino, Ingrid Kreimerman, Eduardo Savio, Henry Engler
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1251;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive & Nonradioactive

  • Relationships between tau, atrophy, regional brain activity and connectivity in Alzheimer's disease: a PET/MRI multimodal study
  • Gray matter structural networks related to 18F-THK5351 retention in cognitively normal older adults and early Alzheimer’s disease patients
  • Assessment of α4β2 nicotinic acetylcholine receptor (nAChR) availability and neuronal response to rewarding food-cues in human obesity using simultaneous PET-MRI
Show more Molecular Targeting Probes - Radioactive & Nonradioactive

Special MTA: Automation & Process Development Posters

  • Radiosynthesis of [18F]FPYBF-2, a novel PET imaging probe for β-amyloid plaques in brain
  • Design, construction, and testing of an inexpensive automated 68Ga-DOTATOC synthesis unit
  • Automated production of 18F-rhodamine 6G for myocardial perfusion imaging
Show more Special MTA: Automation & Process Development Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire